BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Genetown

  Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences

  To date, the investment firm has raised more than $1 billion to invest in drug development companies.

  December 11, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Roche’s Perjeta Breast Cancer Combo Therapy Remains Strong in 6-Year Study Data

  At the six-year mark, 90.6% of patients in the Perjeta cohort have not had breast cancer return, compared to 87.8% in the placebo arm. This comes to an absolute benefit of 2.8%.

  December 11, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Aligos CEO Discusses Progress on Developing HBV Treatments

  Aligos Chief Executive Officer Lawrence Blatt told BioSpace that the different assets in development address different components of the infection.

  December 11, 2019

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  BioSpace Global Roundup, Dec. 12

  Companies from across the globe provide updates to their business and pipelines.

  December 11, 2019

   · 

  6 min read

   · 

  Alex Keown